Gene polymorphisms and elite athletic performance

Journal of Anthropological Sciences

Volumn 86, Issue , 2008, Pages 113-131

  Calò, Carla M ^a   Vona, Giuseppe ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Athletic performance; Genetic markers; Inheritance; Phenotypes

Indexed keywords

EID: 58449125812     PISSN: 18274765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Ahmetov I, Mozhayskaya I.A., Flavell D.M., Astratenkova I.V., Komkova A.I., Lyubaeva E.V., Tarakin P.P., Henkman B.S., Vdovina A.B., Netreba A.I., Popov D.V., Vinogradova O.L., Montgomery H.E. & Rogozin V.A. 2006. PPARα gene variation and physical performance in Russian athletes. Eur. J. Appl. Physiol., 97: 103-108.
2. Booth F.W. & Narahara K.A. 1975. Vastus lateralis cytochrome oxidase activity and its relationship to maximal oxygen consumption in man. Pflugers Arch., 349: 319-324.
3. Bouchard C., Lesage R., Lortie G., Simoneau J.A., Hamel P., Boulay M.R., Pérusse L., Thériault G. & Leblanc C. 1986. Aerobic performance in brothers, dizygotic and monozygotic twins. Med. Sci. Sports Exerc., 18: 639-646.
4. Bramble D.M., Lieberman D.E. 2004. Endurance running and the evolution of Homo. Nature, 432: 345-352.
5. Braun A., Kammerer S., Bohme E., Muller B. & Roscher A.A. 1995. Identifi cation of polymorphic sites of the human bradykinin B2 receptor gene. Biochem. Biophys. Res. Comm., 211: 234-240.
6. Braun A., Kammerer S., Maier E., Bohme E. & Roscher A.A. 1996. Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology, 33: 32-35.
7. Brull D., Dhamrait S., Myerson S., Erdmann J., Woods D., World M., Pennell D., Humphries S., Regitz-Zagrosek V. & Montgomery H. 2001. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet, 358: 1155-1156.
8. Calò C.M., Vona G., Corona F., Massidda M. 2008. Interazioni tra genotipo e fenotipo in ginnasti italiani d'elite. In Atti Convegno Scientifi co Nazionale "La ginnastica artistica nel XXI secolo". Aracne Ed., in press.
9. Cam S., Colakoglu M., Colakoglu S., Sehuri C. & Berdeli A. 2007. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J. Sports Med. Phys. Fitness, 47: 234-238.
10. Castro M.G., Huerta C., Reguero J.R., Soto M.I., Domenech E., Alvarez V., Gomez-Zaera M., Nunes V., Gonzalez P., Corao A. & Coto E. 2006. Mitochondrial haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int. J. Cardiol., 112: 202-206.
11. Castro M.G. Terrados N., Reguero J.R., Alvarez V. & Coto E. 2007. Mitochondrial haplogroup T is negatively associated with the status of elite endurance athletes. Mitochondrion, 7: 354-357.
12. Clarkson P.M. Devaney J.M., Gordish-Dressman H., Thompson P.D., Hubal M.J., Urso M., Price T.B., Angelopoulos T.J., Gordon P.M., Moyna N.M., Pescatello L.S., Visich P.S., Zoeller R.F., Seip R.L. & Hoff man E.P. 2005. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J. Appl. Physiol., 99: 154-163.
13. Colakoglu M., Cam F.S., Kayitken B., Cetinoz F., Colakoglu S., Turkmen M. & Sayin M. 2005. ACE genotype may have an eff ect on single versus multiple set preferences in strength training. Eur. J. Appl. Physiol., 95: 20-26.
14. Costill D.L. 1967. The relationship between selected physiological variables and distance running performance. J. Sports Med. Phys. Fitness, 7: 61-63.
15. Delmonico M.J., Kostek M.C., Doldo N.A., Hand B.D., Walsh S., Conway J.M., Carignan C.R., Roth S.M. & Hurley B.F. 2007. Alphaactinin-3 (ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and women. J. Gerontol. A. Biol. Sci. Med. Sci., 62: 206-212.
16. Depres J.P., Bouchard C., Savard R., Prud'homme D., Bukowiecki L. & Theriault G. 1984. Adaptive changes to training in adipose tissue lipolysis are genotype dependant. Int. J. Obes., 8: 87-95.
17. 2max, and response to endurance training. Med. Sci. Sports Exerc., 23: 177-185.
18. Folland J., Leach B., Little T., Hawker K., Myerson S., Montgomery H. & Jones D. 2002. Angiotensin-converting enzyme genotype aff ects the response of human skeletal muscle to functional overload. Exp. Physiol., 85: 575-579.
19. Gabriel H., Rothe G., Korpys M., Schmitz G. & Kindermann W. 1997. Enhanced expression of HLA-DR, Fc gamma receptor1 (CD64) and leukocyte common antigen (CD45) indicate activation of monocytes in regenerative training periods of endurance athletes. Int. J. Sports Med., 18: 136-141.
20. Gayagay G., Yu B., Hambly B., Boston T., Hahn A., Celermajer D.S. & Trent R.J. 1998. Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum. Genet., 103: 48-50.
21. Gennarelli M., Novelli G., Cobo A., Baiget M. & Dallapiccola B. 1991. 3 creatine kinase (M-type) polymorphisms linked to myotonic dystrophy in Italian and Spanish populations. Hum. Genet., 87: 654-656.
22. Hawley J.A. 2002. Eff ect of increased fat availability on metabolism and exercise capacity. Med. Sci. Sports Exerc., 34: 1485-1491.
23. Hedrick P.W. 2000. Genetics of population. Jones and Bartlett Publisher, Boston, M.A.
24. Heled Y, Moran DS, Mendel L, Laor A, Pras E, Shapiro Y. 2004. Human ACE I/D polymorphism is associated with individual diff erences in exercise heat tolerance. J. Appl. Physiol. 97: 72-76.
25. Henderson J., Withford-Cave J.M., Duff y D.L., Cole S.J., Sawyer N.A., Gulbin J.P., Hahn A., Trent R.J. & Yu B. 2005. The EPAS1 gene infl uences the aerobic-anaerobic contribution in elite endurance athletes. Hum. Genet., 118: 416-423.
26. Hoehe M.R., Berrettini W.H. & Lentes K.U. 1986. Dra I identifi es a two allele DNA polymorphism in the human alpha 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res., 16: 9070.
27. Hopkins WG. 2001. Genes and training for athletic performance. Sportscience, 5 : 1 sportsci.org/jour/0101/wghgene.htm.
28. Hruskovicova H., Dzurenkova D., Selingerova M., Bohus B. Tikanicova B. & Kovacs L. 2006. The angiotensin converting enzyme I/D polymorphism in log distance runners. J. Sports Med. Phys. Fitness, 46: 509-513.
29. Kobilka B.K., Dixon R.A., Frielle T., Dohlman H.G., Bolanowski M.A., Sigal I.S., Yang-Feng T.L., Francke U., Caron M.G. & Lefkowitz R.J. 1987. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A., 84: 46-50.
30. Lafontan M. & Berlan M. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res., 34: 1057-1091.
31. Larsen H.B. 2003. Kenyan dominance in distance running. Comp. Biochem. Physiol. A Mol. Intergr. Physiol., 36: 161-170,
32. Lavedan C., Duros C., Savoy D., Leblond S., Baily J., Korneluk R. & Junien C. 1990. Direct Haplotyping by double digestion of PCR amplifi ed creatine kinase (CKMM): amplifi cation to myotonic dystrophy diagnosis. Genomics 8: 739-740.
33. Lentes K.U., Berrettini W.H., Hoehe M.R., Chung F.Z. & Gershon E.S. 1988. A biallelic DNA polymorphism of the human beta-2-adrenergic receptor detected by Ban I-Adrbr-2. Nucleic Acids Res., 16: 2359.
34. Lesage R., Simoneau J.A., Jobin J., Leblanc J. & Bouchard C. 1985. Familial resemblance in maximal hart rate, blood lactate and aerobic power. Hum. Hered., 35: 182-189.
35. Lieberberg L. 2006. Persistence hunting by modern hunter-gatherers. Curr. Anthrop., 47: 1017-1026.
36. Lieberman D.E., Bramble D.M. 2007. The evolution of marathon running: capabilities in humans. Sports Med., 37: 288-290.
37. Lin J., Wu., Tarr P.T., Zhang C.Y., Wu Z., Boss. O., Michael L.F., Puigserver P., Isotani E., OlsonE.N., Lowell B.B., Bassel-Duby R. & Spiegelman B.M. 2002. Transcriptional coactivator PGC-1alpha drives the formation of slow-twitch muscle fi bres. Nature, 418: 797-801.
38. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., Beck-Neilsen H., Groop H. & Vaag A. 2004. Multiple environmental and genetics factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest., 114: 1518-1526.
39. Lucia A., Gomez-Gallego F., Santiago C., Bandres F., Earnest C., Rabadan M., Alonso J.M., Hoyos J., Cordova A., Villa G. & Foster C. 2006. ACTN3 genotype in professional endurance cyclists. Int. J. Sports Med., 27: 880-884.
40. Lucia A., Gomez-Gallego F., Barroso I., Rabadan M., Bandres F., San Juan A.F., Chicharo J.L., Ukelund U. Brage S., Earnest C.P., Wareham N.J. & Franks P.W. 2005. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J. Appl. Physiol., 99: 344-348.
41. Lung C.C., Chan E.K. & Zuraw B.L. 1997. Analysis of an exon 1 polymorphism of the B2 bradyinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor defi ciency. J. Allergy Clin. Immunol., 99: 134-146.
42. Lupski J.R. 2007. An evolution revolution provides further revelation. Bioessays, 29: 1182-1184.
43. Maldonado S., Mujika L. & Padilla S. 2002. Influence of body mass and weight on the energy cost of running in highly trained middle- and long distance runners. Int. J. Sports Med., 23: 268-272.
44. McArthur D.G. & North K.N.2004. A gene for speed? The evolution and function of α-actinin-3. BioEssays, 26: 786-795.
45. McArthur D.G. & North K.N.2005. Genes and human elite athletic performance. Hum. Genet., 116: 331-339.
46. Mills M., Yang N., Weinberger R., Vander Woude D.L., Beggs A.H., Easteal S. & North K. 2001. Diff erential expression of the actinbinding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet., 10: 1335-1346.
47. Montgomery H., Clarkson P., Barnard M., Bell J., Brynes A., Dollery C., Hajnal J., Hemingway H., Mercer D., Jarman P., Marshall R., Prasad K., Rayson M., Saeed N., Talmud P., Thomas L., Jubb M., World M. & Humphries S. 1999. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet., 353: 541-545.
48. Montgomery H., Safari L. 2007. Genetic basis of physical fitness. Annu. Rev. Anthropol., 36: 391-405.
49. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Delay M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirshborn J.N., Altshuler D. & Groop L.C. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nat. Genet., 34: 267-273.
50. Moran C.N. Yang N., Bailey M.E.S., Tsiokanos A., Jamurtas A., MacArthur D.G., North K., Pitsiladis Y.P. & Wilson R.H. 2007. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur. J. Hum. Genet., 15: 88-93.
51. Murakami H., Ota A., Simojo H., Okada M., Ajisaka R. & Kuno S. 2002. Polymorphism in control region of mtDNA relates to individual diff erences in endurance capacity of trainability. Jpn J. Physiol., 52: 247-256.
52. Murphey L.J., Gainer J.V., Vaughan D.E. & Brown N.J. 2000. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation, 102: 829-832.
53. Myerson S., Hemingway H., Budget R., Martin J., Humphries S. & Montgomery H. 1999. Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol., 87: 1313-1316.
54. Niemi A.K. & Majamaa K. 2005. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sport athletes. Eur. J. Hum. Genet., 13: 965-969.
55. Norrbom J. Sundberg C.J., Ameln H. Kraus W.E., Jansson E. & Gustafsson T. 2004. PGC-1alpha mRNA expression is infl uenced by metabolic perturbation in exercising human skeletal muscle. J. Appl. Phyiol., 96: 189-194.
56. North K.N. & Beggs A.H. 1996. Defi ciency of a skeletal muscle isoform of alpha-actinin (alpha-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul. Disord., 6: 229-235.
57. Perusse L., Gagnon J., Province M.A., Rao D.C., Wilmore J.H., Leon A.S., Bouchard C. & Skinner J.S. 2001. Familial aggregation of submaximal aerobic performance in the HERITAGE Family study. Med. Sci. Sports Exerc., 33: 597-604.
58. Prud'homme D., Bouchard C., Leblanc C., Landry F. & Fontaine E. 1984. Sensitivity of maximal aerobic power to training is genotype-dependent. Med. Sci. Sports Exerc., 16: 489-493.
59. Rankinen T., Bary M.S., Hagberg J.M., Perusse L., Roth S.M., Wolfarth B. & Bouchard C. 2006. The human gene map for performance and health-related fi tness phenotype: the 2005 update. Med. Sci. Sports Exerc., 38: 1863-1888.
60. Rankinen T., Perusse L., Boreski I., Chagnon Y.C., Gagnon J., Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C. & Bouchard C. 2000. The Na+-K+-ATPase α2 gene and trainability of cardiorespiratory endurance: the HERITAGE Family Study. J. Appl. Physiol., 88: 346-351.
61. Rico-Sanz J., Rankinen YT., Rice T. Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C. & Bouchard C. 2004. Quantitative trait loci for maximal exercise capacity phenotypes and their responses to training in the HERITAGE Family Study. Physiol. Genomics, 16: 256-660.
62. Rodas G., Ercilla G., Javierre C., Garido E., Calvo M., Segura R. & Ventura J.L. 1997. Could the A2A11 human leukocyte antigen locus correlate with maximal aerobic power? Clin. Sci. (Lond.), 92: 331-333.
63. Romero R., Kuivaniemi H., Tromp G. & Olson J. 2002. The design execution, and interpretation of genetic association studies to decipher complex diseases. Am. J. Obstet. Gynecol., 187: 1299-1312.
64. Rigat B., Hubert C., Ajhenc-Gelas F., Cambien F., Corvol P. &, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86: 1343-1346.
65. 2max in the HERITAGE Family Study. Med. Sci. Sports Exerc., 29: 1311-1317.
66. Rivera M.A., Dionne F.T., Wolfarth B., Chagnon M., Simoneau J.A., Perusse L., Boulay M.R., Gagnon J., Song T.M., Keul J. & Bouchard C. 1997b. Muscle-specifi c creatine kinase gene polymorphisms in elite endurance athletes and sedentary controls. Med. Sci. Sports Exerc., 29: 1444-1447.
67. Rufo F. 2007. The genome and public choices: new questions for Anthropology. J. Anthropol. Sci., 85: 205-211.
68. Russell A.P., Feilchenfeldt J., Schreiber S., Praz M., Crettenand A., Gobelet C., Meier C.A., Bell D.R., Kralli A., Giacobino J.P. & Dériaz O. 2003. Endurance training in humans leads to fi ber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferatoractivated receptor-alpha in skeletal muscle. Diabetes, 52: 2874-2881.
69. Schmiedel J., Jackson S., Schafer J. & Reichmann H. 2003. Mitochondrial cytopathies. J. Neurol., 250: 267-277.
70. Scott R.A., Wilson R.H., Goodwin W.H., Moran C.N., Georgiades E., Wolde B. & Pitsiladis Y.P. 2005. Mitochondrial DNA lineage of elite Ethiopian athletes. Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 14: 497-503.
71. Tanriverdi H., Evrengul H., Tanriverdi S., Turgut S., Akdag B., Kaftan H.A. & Semiz E. 2005. Improved endothelium dependent vasodilatation in endurance athletes and its relation with ACE I/D polymorphism. Cardiology,69: 1105-1110.
72. Tsianos G., Sanders J., Dhamrait S., Humphries S., Grant S. & Montgomery H. 2004. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur. J. Appl. Physiol., 92: 360-362.
73. Vona G. 2008. Genetica e performance sportiva nella ginnastica artistica. In Atti del Convegno Scientifi co Nazionale "La Ginnastica Artistica nel XXI secolo". Aracne Ed., in press.
74. Wicklmayr M., Dietze G., Brunnbauer H., Rett K. & Mehnert H. 1983. Dose-dependent effect of bradykinin on muscular blood flow and glucose uptake in man. Hoppe Seylers Z. Physiol. Chem., 364: 831-833.
75. Williams AG, Day SH, Folland JP, Gohlke P, Dhamrait S, Montgomery HE.Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med. Sci. Sports Exerc., 37:944-948, 2005.
76. Williams A.G., Dhamrait S.S., Wootton P.T., Day S.H., Hawe E., Payne J.R., Myerson S.G., World M., Budgett R., Humphries S.E. & Montgomery H.E. 2004. Bradykinin receptor gene variant and human physical performance. J. Appl. Physiol., 96: 938-942.
77. Wolfarth B., Rivera M.A., Oppert J.M., Boulay M.R., Dionne F.T., Chagnon M., Gagnon J., Chagnon Y., Perusse L., Keul J. & Bouchard C. 2000. A polymorphism in the alpha2a-adrenoceptor gene and endurance athletes status. Med. Sci. Sports Exerc., 32: 1709-1712.
78. Woods D., Hickman M., Jamshidi Y., Brull D., Vassiliou V., Jones A., Humphries S. & Montgomery H. 2001. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum. Genet., 108:230-232.
79. Yamashita K. & Yoshioka T. 1991. Profiles of creatine kinase isoenzyme composition in single muscle fibers of diff erent types. J. Muscle Res. Cell. Motil., 12: 37-44.
80. Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H., Easteal S. & North K. 2003. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet., 73: 627-631.
81. Yong Kang B., Yang Kang C. & Oh Lee K. 2003. Muscle-specific creatine kinase gene polymorphisms in Korean elite athletes. J. Toxicol. Pub. Health, 19: 115-121.
82. Zhang B., Tanaka H., Shono N. Miura S., Kiyonaga A., Shindo M. & Saku K. 2003. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fi bers in human skeletal muscle. Clin. Genet., 63: 139-144.